Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 3
Submit an article Journal homepage
370
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma

Manuela GiacheliaIstituto di Ematologia
,
Maria Teresa VosoIstituto di Ematologia
,
Maria Chiara TisiIstituto di Ematologia
,
Maurizio MartiniIstituto Anatomia Patologica, Universita’ Cattolica S. Cuore, Rome, Italy
,
Valentina BozzoliIstituto di Ematologia
,
Giuseppina MassiniIstituto di Ematologia
,
Francesco D'AlóIstituto di Ematologia
,
Luigi Maria LaroccaIstituto Anatomia Patologica, Universita’ Cattolica S. Cuore, Rome, Italy
,
Giuseppe LeoneIstituto di Ematologia
&
Stefan HohausIstituto di EmatologiaCorrespondence[email protected]
 show all
Pages 411-416 | Received 09 Jun 2011, Accepted 04 Sep 2011, Published online: 24 Oct 2011

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Qixiang Rong, Yan Gao, Qichun Cai, Xiaoxiao Wang, Bing Bai, Liqin Ping, Haixia He, Huilan Rao, Yujing Zhang, Zhiming Li, Qingqing Cai, Wenqi Jiang & Huiqiang Huang. (2021) High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL). Expert Review of Anticancer Therapy 21:1, pages 121-127.
Read now
Bodo E. Lippitz & Robert A. Harris. (2016) Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis . OncoImmunology 5:5.
Read now
Kaspar Rene Nielsen, Rudi Steffensen, Thure Mors Haunstrup, Julie Støve Bødker, Karen Dybkær, John Baech, Martin Bøgsted & Hans Erik Johnsen. (2015) Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma. Leukemia & Lymphoma 56:12, pages 3257-3266.
Read now
Maria Chiara Tisi, Valentina Bozzoli, Manuela Giachelia, Giuseppina Massini, Bianca Maria Ricerca, Elena Maiolo, Francesco D’Alo’, Luigi Maria Larocca, Alfonso Piciocchi, Harold Tjalsma, Dorine W. Swinkels, Maria Teresa Voso, Giuseppe Leone & Stefan Hohaus. (2014) Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. Leukemia & Lymphoma 55:2, pages 270-275.
Read now
Fabrice Jardin, Marie Hélène Delfau-Larue, Thierry Jo Molina, Christiane Copie-Bergman, Josette Brière, Tony Petrella, Danielle Canioni, Bettina Fabiani, Jean-Philippe Jais, Martin Figeac, Karen Leroy, Sylvain Mareschal, Gilles André Salles, Bertrand Coiffier, Richard Delarue, Frédéric Peyrade, André Bosly, Marc André, Nicolas Ketterer, Corinne Haioun & Hervé Tilly. (2013) Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma. Leukemia & Lymphoma 54:9, pages 1898-1907.
Read now

Articles from other publishers (28)

Mark Roschewski, Manish R. Patel, Patrick M. Reagan, Nakhle S. Saba, Graham P. Collins, Hendrik-Tobias Arkenau, Sven de Vos, Barrett Nuttall, Melih Acar, Kathleen Burke, Rafael D. White, Maria Udriste, Shringi Sharma, Brian Dougherty, Daniel Stetson, David Jenkins, Andrew Mortlock, Alessandra Forcina, Veerendra Munugalavadla & Ian Flinn. (2023) Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment. Clinical Cancer Research 29:17, pages 3301-3312.
Crossref
Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki & Akira Satou. (2023) The Immunology of DLBCL. Cancers 15:3, pages 835.
Crossref
Toshikage Nagao, Kota Yoshifuji, Daichi Sadato, Yotaro Motomura, Makiko Saito, Kurara Yamamoto, Kouhei Yamamoto & Ayako Nogami. (2022) Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12. Experimental Hematology 116, pages 37-49.
Crossref
Ra Ri Cha, Dong Hoon Baek, Gyeong Won Lee, Seun Ja Park, Jong Hoon Lee, Jong Ha Park, Tae Oh Kim, Sang Heon Lee, Hyung Wook Kim & Hyun Jin Kim. (2021) Clinical Features and Prognosis of Patients with Primary Intestinal B-cell Lymphoma Treated with Chemotherapy with or without Surgery. The Korean Journal of Gastroenterology 78:6, pages 320-327.
Crossref
Samy Y. Elkhawaga, Maher H. Gomaa, Mohsen M. Elsayed & Ahmed A. Ebeed. (2021) NFKB1 promoter –94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients. Clinical Rheumatology 40:7, pages 2927-2937.
Crossref
Georges El Hasbani, Ali T. Taher, Alain S. Abi-Ghanem, Samer Nassif, Abdul Rahman Bizri & Imad Uthman. (2021) Polymyalgia rheumatica-like presentation in a case of diffuse large B-cell lymphoma: a diagnostic pitfall. Journal of International Medical Research 49:5, pages 030006052110185.
Crossref
Qian Luo, Chunli Yang, Chunxi Fu, Wanchun Wu, Yi Wei & Liqun Zou. (2021) Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy. Frontiers in Oncology 11.
Crossref
Eivind Heggernes Ask, Astrid Tschan-Plessl, Thea Johanne Gjerdingen, Michelle Lu Sætersmoen, Hanna Julie Hoel, Merete Thune Wiiger, Johanna Olweus, Björn E. Wahlin, Ole Christian Lingjærde, Amir Horowitz, Amanda F. Cashen, Marcus Watkins, Todd A. Fehniger, Harald Holte, Arne Kolstad & Karl-Johan Malmberg. (2021) A Systemic Protein Deviation Score Linked to PD-1+ CD8+ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma. Med 2:2, pages 180-195.e5.
Crossref
Weijie Zhong, Zhigang Zhu, Xin Xu, Hui Zhang, Huabao Xiong, Qingshan Li & Yaming Wei. (2019) Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Mukesh Verma, Debmalya Barh & Syed Shah Hassan. 2019. Genomics and Clinical Diagnostics. Genomics and Clinical Diagnostics 494 530 .
Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård, Jessica Wenthe, Tanja Lövgren, Rose Marie Amini, Kristina I. Wikstrom, Magnus Essand, Barbara Savoldo, Helene Hallböök, Martin Höglund, Gianpietro Dotti, Malcolm K. Brenner, Hans Hagberg & Angelica Loskog. (2018) A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia. Clinical Cancer Research 24:24, pages 6185-6194.
Crossref
Yi-Ru Pan, Chih-Cheng Chen, Yu-Tien Chan, Hsiao-Jung Wang, Fan-Tso Chien, Yeng-Long Chen, Jing-Lan Liu & Muh-Hwa Yang. (2018) STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas. Nature Communications 9:1.
Crossref
Amin Zhang, Jie Yu, Shuxin Yan, Xia Zhao, Chen Chen, Ying Zhou, Xueyun Zhao, Mingqiang Hua, Ruiqing Wang, Chen Zhang, Chaoqin Zhong, Na He, Chunyan Ji & Daoxin Ma. (2018) The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia. Human Immunology 79:1, pages 57-62.
Crossref
Ivan Dlouhy, Xavier Filella, Jordina Rovira, Laura Magnano, Alfredo Rivas-Delgado, Tycho Baumann, Alejandra Martínez-Trillos, Olga Balagué, Antonio Martínez, Blanca González-Farre, Kennosuke Karube, Eva Gine, Julio Delgado, Elías Campo & Armando López-Guillermo. (2017) High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma. Leukemia Research 59, pages 20-25.
Crossref
Theo S Plantinga, Mirela S Petrulea, Marije Oosting, Leo A B Joosten, Doina Piciu, Johannes W Smit, Romana T Netea-Maier & Carmen E Georgescu. (2017) Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma. Endocrine-Related Cancer 24:7, pages 287-298.
Crossref
Angela Falduto, Francesco Cimino, Antonio Speciale, Caterina Musolino, Sebastiano Gangemi, Antonella Saija & Alessandro Allegra. (2017) How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma. Blood Reviews 31:4, pages 235-249.
Crossref
Wen Fu, Zhen-Jian Zhuo, Yung-Chang Chen, Jinhong Zhu, Zhang Zhao, Wei Jia, Jin-Hua Hu, Kai Fu, Shi-Bo Zhu, Jing He & Guo-Chang Liu. (2016) NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies . Oncotarget 8:6, pages 9806-9822.
Crossref
F Pauly, K Fjordén, S Leppä, H Holte, M Björkholm, Ø Fluge, L Møller Pedersen, M Eriksson, A Isinger-Ekstrand, C A K Borrebaeck, M Jerkeman & C Wingren. (2016) Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study. Blood Cancer Journal 6:11, pages e501-e501.
Crossref
Jing Wang, Min Zhou, Xiaoyue Wang, Jingyan Xu, Bing Chen & Jian Ouyang. (2016) Pretreatment C-reactive protein was an independent prognostic factor for patients with diffuse large B-cell lymphoma treated with RCHOP. Clinica Chimica Acta 459, pages 150-154.
Crossref
Rosalba Camicia, Hans C. Winkler & Paul O. Hassa. (2015) Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Molecular Cancer 14:1.
Crossref
Katharina T. Troppan, Thomas Melchardt, Alexander Deutsch, Konstantin Schlick, Tatjana Stojakovic, Marc D. Bullock, Daniel Reitz, Christine Beham-Schmid, Lukas Weiss, Daniel Neureiter, Kerstin Wenzl, Richard Greil, Peter Neumeister, Alexander Egle & Martin Pichler. (2015) The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients. European Journal of Haematology 95:6, pages 538-544.
Crossref
Hugo J.A. Adams, John M.H. de Klerk, Rob Fijnheer, Ben G.F. Heggelman, Stefan V. Dubois, Rutger A.J. Nievelstein & Thomas C. Kwee. (2015) Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 15:11, pages 671-679.
Crossref
Linda M. Scott & Maher K. Gandhi. (2015) Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies. Blood Reviews 29:6, pages 405-415.
Crossref
Sophie Bernard, Damien Danglade, Laura Gardano, Christelle Laguillier, Gregory Lazarian, Claudine Roger, Catherine Thieblemont, Jacek Marzec, John Gribben, Florence Cymbalista, Nadine Varin-Blank, Dominique Ledoux & Fanny Baran-Marszak. (2015) Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma. International Journal of Cancer 136:12, pages 2761-2774.
Crossref
Ya‐Jun Li, Wen‐Qi Jiang, Jia‐Jia Huang, Zhong‐Jun Xia, Hui‐Qiang Huang & Zhi‐Ming Li. (2013) The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T‐cell lymphoma, nasal type. American Journal of Hematology 88:5, pages 394-399.
Crossref
Hsin-Yi Yang, Kuo-Cheng Lu, Herng-Sheng Lee, Shih-Ming Huang, Yuh-Feng Lin, Chia-Chao Wu, Donald M. Salter & Sui-Lung Su. (2013) Role of the Functional Toll-Like Receptor-9 Promoter Polymorphism (-1237T/C) in Increased Risk of End-Stage Renal Disease: A Case-Control Study. PLoS ONE 8:3, pages e58444.
Crossref
Fabrice Jardin & Hervé Tilly. 2013. Lymphoma. Lymphoma 177 202 .
. (2012) Current World Literature. Current Opinion in Oncology 24:5, pages 587-595.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.